The top four reasons why clinicians do not test Lp(a) are a lack of specific guidelines on how to manage patients with raised levels, a lack of harmonised guidelines on who should be tested, a lack of approved Lp(a) lowering treatments, and a lack of awareness about the importance of Lp(a) as a risk factor.